Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease
DIPAK 1 研究的原理和设计:一项随机对照临床试验,旨在评估兰瑞肽治疗常染色体显性多囊肾病阻止疾病进展的疗效。
期刊:American Journal of Kidney Diseases
影响因子:8.2
doi:10.1053/j.ajkd.2013.10.011
Meijer, Esther; Drenth, Joost P H; d'Agnolo, Hedwig; Casteleijn, Niek F; de Fijter, Johan W; Gevers, Tom J; Kappert, Peter; Peters, Dorien J M; Salih, Mahdi; Soonawala, Darius; Spithoven, Edwin M; Torres, Vicente E; Visser, Folkert W; Wetzels, Jack F M; Zietse, Robert; Gansevoort, Ron T